Cure My Disease

Don't miss your cure!

 Log in / Sign up

Real-World data sheds light on promising lymphoma treatment

NCT ID NCT06994169

Recruiting now Disease control Sponsor: The Lymphoma Academic Research Organisation Source: ClinicalTrials.gov ↗

Summary

This study looks back at the medical records of about 250 patients in France who have already received a lymphoma drug called Glofitamab. The goal is to understand how well the treatment worked and how safe it was in everyday medical practice, especially for patients whose cancer came back after other advanced treatments. Researchers will analyze outcomes like survival and side effects from this large group.

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for LARGE B-CELL LYMPHOMA are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • CH Victor Dupouy

    RECRUITING

    Argenteuil, 95100, France

    Contact

  • CH d'Avignon - Hôpital Henri Dufaut

    RECRUITING

    Avignon, 84000, France

    Contact

  • CH de Dunkerque

    RECRUITING

    Dunkirk, France

    Contact

  • CH de Mulhouse Sud Alsace

    RECRUITING

    Mulhouse, 68070, France

    Contact

  • CH de Quimper Cornouaille

    RECRUITING

    Quimper, 29107, France

    Contact

  • CH de la Côte Basque

    RECRUITING

    Bayonne, France

    Contact

  • CHR d'Orléans

    RECRUITING

    Orléans, France

    Contact

  • CHRU Besançon - Hôpital Minjoz

    RECRUITING

    Besançon, France

    Contact

  • CHRU de LILLE - Claude Huriez

    RECRUITING

    Lille, France

    Contact

  • CHRU de Nancy - Hôpital de Brabois

    RECRUITING

    Vandœuvre-lès-Nancy, France

    Contact

  • CHU Lyon Sud

    RECRUITING

    Pierre-Bénite, France

    Contact

  • CHU de Dijon - Hôpital le Bocage

    RECRUITING

    Dijon, 21000, France

    Contact

  • CHU de Grenoble - Hôpital Albert Michallon

    RECRUITING

    La Tronche, France

    Contact

  • CHU de Poitiers - Hôpital de La Milétrie

    RECRUITING

    Poitiers, France

    Contact

  • CHU de Rennes - Hôpital de Pontchaillou

    RECRUITING

    Rennes, France

    Contact

  • CHU de Strasbourg

    RECRUITING

    Strasbourg, France

    Contact

  • Centre Léon Bérard

    RECRUITING

    Lyon, 69373, France

    Contact

  • Ch de Bretagne Atlantique

    RECRUITING

    Vannes, France

    Contact

  • Chu Bretonneau

    RECRUITING

    Tours, France

    Contact

  • Chu de Bordeaux - Hopital Haut-Leveque

    RECRUITING

    Pessac, France

    Contact

  • Clinique du Pont de Chaume

    RECRUITING

    Montauban, France

    Contact

  • Gustave Roussy Cancer Campus Grand Paris

    RECRUITING

    Villejuif, France

    Contact

  • Hopital D'Instruction Des Armees Percy

    RECRUITING

    Clamart, 92141, France

    Contact

  • Hopital Henri Mondor

    RECRUITING

    Créteil, France

    Contact

  • Hopital Saint Vincent-de-Paul

    RECRUITING

    Lille, France

    Contact

  • Hopital Saint-Louis

    RECRUITING

    Paris, France

    Contact

  • Hôpital de Libourne

    RECRUITING

    Libourne, France

    Contact

  • INSTITUT PAOLI CALMETTES - Service Hématologie

    RECRUITING

    Marseille, France

    Contact

  • Institut Curie - Site Saint-Cloud

    RECRUITING

    Saint-Cloud, France

    Contact

  • Institut Universitaire du Cancer de Toulouse - Oncopole

    RECRUITING

    Toulouse, France

    Contact

Conditions

Explore the condition pages connected to this study.

LARGE B-CELL LYMPHOMA